16 results
10-Q
2024 Q1
TCBP
TC BioPharm (Holdings) plc
15 May 24
Quarterly report
4:06pm
adopted a new share option scheme, or the 2021 Share Option Scheme, for the purpose granting share options to incentivize the Company’s directors
10-K/A
2023 FY
TCBP
TC BioPharm (Holdings) plc
29 Apr 24
Annual report (amended)
5:23pm
to the Company of approximately $2.8 million. In order to incentivize the inducement, the Company issued 623,750 Series D warrants to the Series, A, B and C
10-K
2023 FY
TCBP
TC BioPharm (Holdings) plc
1 Apr 24
Annual report
5:11pm
). The inducement resulted in gross proceeds to the Company of approximately $2.8 million. In order to incentivize the inducement, the Company issued 623,750 … . In order to incentivize the inducement, the Company issued 623,750 Series D warrants to the Series, A, B and C warrant holders. In addition, the Company
6-K
EX-99.1
TCBP
TC BioPharm (Holdings) plc
2 Nov 23
Current report (foreign)
12:57pm
, for the purpose granting share options to incentivize our directors, employees and consultants and the directors, employees and consultants of our
6-K
EX-99.1
fh5ba
12 Dec 22
Current report (foreign)
9:00am
20-F
8cmdifjsxeopcpfmi
13 May 22
Annual report (foreign)
3:56pm
424B4
px30z4 gdt3
2 Mar 22
Prospectus supplement with pricing info
12:03pm
424B4
1jqgwjbdqfvup
14 Feb 22
Prospectus supplement with pricing info
5:10pm
424B4
pug5lfbvnqwno
14 Feb 22
Prospectus supplement with pricing info
12:00am
F-1/A
qbmqf4e1z61f j3
9 Feb 22
Registration statement (foreign) (amended)
5:01pm
F-1/A
clp889j7w
31 Jan 22
Registration statement (foreign) (amended)
4:51pm
F-1/A
e1dw81
14 Jan 22
Registration statement (foreign) (amended)
5:29pm
F-1/A
jwjzxfxru6lhui9cru
23 Dec 21
Registration statement (foreign) (amended)
5:14pm
F-1/A
1yna vzax
27 Oct 21
Registration statement (foreign) (amended)
1:47pm
F-1
kj2cvjusyl9a61b
26 Oct 21
Registration statement (foreign)
12:00am
- Prev
- 1
- Next